{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:05:03Z","timestamp":1774364703561,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jchromb.2024.124209","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:32:26Z","timestamp":1718422346000},"page":"124209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacokinetic assessment of low dose decitabine in combination therapies: Development and validation of a sensitive UHPLC-MS\/MS method for murine plasma analysis"],"prefix":"10.1016","volume":"1242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1317-8460","authenticated-orcid":false,"given":"Nadeen","family":"Anabtawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Drabison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Eisenmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Sparreboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajgopal","family":"Govindarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharyn D.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2024.124209_b0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/asheducation-2017.1.54","article-title":"The role of targeted therapy in the management of patients with AML","volume":"1","author":"Perl","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jchromb.2024.124209_b0010","article-title":"Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translation","volume":"4","author":"Rodriguez-Sevilla","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jchromb.2024.124209_b0015","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/ajh.26667","article-title":"Hypomethylating agents for the treatment of myelodysplastic syndromes and acute myeloid leukemia: Past discoveries and future directions","volume":"97","author":"Short","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jchromb.2024.124209_b0020","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/cncr.23463","article-title":"Evolution of decitabine development: accomplishments, ongoing investigations, and future strategies","volume":"112","author":"Jabbour","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jchromb.2024.124209_b0025","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1053\/j.seminhematol.2005.05.002","article-title":"Pharmacology of 5-Aza-2\u2032-deoxycytidine (decitabine)","volume":"42","author":"Momparler","year":"2005","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jchromb.2024.124209_b0030","unstructured":"EMA. (2012) Human medicines: Dacogen (decitabine) Agency product number: EMEA\/H\/C\/002221. London, UK."},{"key":"10.1016\/j.jchromb.2024.124209_b0035","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s40265-020-01389-7","article-title":"Decitabine\/cedazuridine: first approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.jchromb.2024.124209_b0040","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1182\/bloodadvances.2020002929","article-title":"Cedazuridine\/decitabine: from preclinical to clinical development in myeloid malignancies","volume":"5","author":"Patel","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jchromb.2024.124209_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.06.026","article-title":"LC\u2013MS\/MS method for the quantitation of decitabine and venetoclax in rat plasma after SPE: Application to pharmacokinetic study","volume":"31","author":"Alnasser","year":"2023","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.jchromb.2024.124209_b0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jchromb.2014.08.012","article-title":"Development and validation of a HILIC\u2013MS\/MS method for quantification of decitabine in human plasma by using lithium adduct detection","volume":"969","author":"Hua","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jchromb.2024.124209_b0055","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/rcm.2423","article-title":"Characterization of decomposition products and preclinical and low dose clinical pharmacokinetics of decitabine (5-aza-2\u2032-deoxycytidine) by a new liquid chromatography\/tandem mass spectrometry quantification method","volume":"20","author":"Liu","year":"2006","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.jchromb.2024.124209_b0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jchromb.2007.12.014","article-title":"Simultaneous determination of decitabine and vorinostat (Suberoylanalide hydroxamic acid, SAHA) by liquid chromatography tandem mass spectrometry for clinical studies","volume":"863","author":"Patel","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jchromb.2024.124209_b0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jchromb.2012.05.005","article-title":"Development and validation of a liquid chromatography\u2013tandem mass spectrometry method for quantification of decitabine in rat plasma","volume":"899","author":"Xu","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jchromb.2024.124209_b0070","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1038\/s41598-019-41070-y","article-title":"Tracking Decitabine Incorporation into Malignant Myeloid Cell DNA in vitro and in vivo by LC-MS\/MS with Enzymatic Digestion","volume":"9","author":"Chilakala","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jchromb.2024.124209_b0075","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1208\/s12248-012-9427-5","article-title":"In Vivo Quantification of Active Decitabine-Triphosphate Metabolite: A Novel Pharmacoanalytical Endpoint for Optimization of Hypomethylating Therapy in Acute Myeloid Leukemia","volume":"15","author":"Wang","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.jchromb.2024.124209_b0080","unstructured":"FDA, Bioanalytical method validation guidance for industry, US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research and Center for Veterinary Medicine, (2018)."},{"key":"10.1016\/j.jchromb.2024.124209_b0085","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.21769\/BioProtoc.3056","article-title":"Murine pharmacokinetic studies","volume":"8","author":"Leblanc","year":"2018","journal-title":"Bio Protoc"},{"key":"10.1016\/j.jchromb.2024.124209_b0090","first-page":"231","article-title":"Oral azacitidine and cedazuridine approximate parenteral azacitidine efficacy in murine model, Target","volume":"15","author":"Ramsey","year":"2020","journal-title":"Oncol"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224002186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224002186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T18:40:40Z","timestamp":1720032040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224002186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":18,"alternative-id":["S1570023224002186"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124209","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic assessment of low dose decitabine in combination therapies: Development and validation of a sensitive UHPLC-MS\/MS method for murine plasma analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"124209"}}